Bone and Joint Infections Clinical MDT Group

Antonia Scobie (Group founder, Chair)

Phage-UK co-founder 

Consultant in Infectious Diseases and Microbiology, Department of Infection at the Royal Free London NHS Foundation Trust, Research lead for Bone Infection unit at the Royal National Orthopaedic Hospital NHS Trust. 

Honorary Associate Professor, Division of Infection and Immunity, UCL.

Specialist interests in orthopaedic and implant-associated

Tariq AZAMGARHI

Phage-UK co-founder 

Antimicrobial pharmacist at the Royal National Orthopaedic Hospitals NHS Trust, specialised in the treatment of bone infections within the MDT. His interests include OPAT and antimicrobial stewardship. He also has a research interest and is currently undertaking a PhD project on surgical prophylaxis in primary bone sarcomas.

Simon Warren (Royal National Orthopaedic Hospital)

Stephen Mepham (Royal Free London)

Nurfarah Sabtu (University Hospitals Coventry and Warwickshire)

Madelaine Winterton (University Hospitals Coventry and Warwickshire)

Phil Michelmore (Royal Devon and Exeter Hospital)

Anna Reed (Harefield part of Guy's and St Thomas)

Mary Carroll (University Hospital Southampton)

Pranabashis Haldar (University of Leicester and University Hospitals of Leicester) 

Rebecca Lester (Royal Free London) 

Philippa Moore (Gloucestershire Hospitals)

Rohma Ghani (University College London Hospitals) 

Saul Faust (University Hospital Southampton)

Dominic Hughes (Royal Brompton Hospital and Imperial College London)

Helen Spencer (Great Ormond Street Hospital) 

Dr. Ben Temperton

Phage-UK co-founder 

Associate Professor of Microbiology at the University of Exeter, specializing in phage therapeutics and antimicrobial resistance, combining microbial genomics, synthetic biology, and bioinformatics to translate cutting-edge science into clinical solutions.

Founder of the Citizen Phage Library, pioneering platforms for phage discovery, engineering, and manufactur

Stéphanie Lesage

Phage-UK co-founder 

CEO at OSPT Ltd, a company she co-founded in 2020, developing a novel antibacterial material integrating bacteriophages to produce medical implants which will reduce surgical site infections and antibiotic use.